The global rheumatic fever market is witnessing a rapid increase in revenues. Market growth is attributed to the rising prevalence of rheumatic fever and the development of many breakthrough drugs and therapeutics. Besides, factors such as the increasing government expenditure for the healthcare sector contribute to market growth. Moreover, COVID 19 pandemic is expected to escalate the market growth to furthered heights during the estimated period.
read more..